These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33472522)

  • 61. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.
    Gustafsson JT; Simard JF; Gunnarsson I; Elvin K; Lundberg IE; Hansson LO; Larsson A; Svenungsson E
    Arthritis Res Ther; 2012; 14(2):R46. PubMed ID: 22390680
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lymphoma risk in systemic lupus: effects of disease activity versus treatment.
    Bernatsky S; Ramsey-Goldman R; Joseph L; Boivin JF; Costenbader KH; Urowitz MB; Gladman DD; Fortin PR; Nived O; Petri MA; Jacobsen S; Manzi S; Ginzler EM; Isenberg D; Rahman A; Gordon C; Ruiz-Irastorza G; Yelin E; Bae SC; Wallace DJ; Peschken CA; Dooley MA; Edworthy SM; Aranow C; Kamen DL; Romero-Diaz J; Askanase A; Witte T; Barr SG; Criswell LA; Sturfelt GK; Blanco I; Feldman CH; Dreyer L; Patel NM; St Pierre Y; Clarke AE
    Ann Rheum Dis; 2014 Jan; 73(1):138-42. PubMed ID: 23303389
    [TBL] [Abstract][Full Text] [Related]  

  • 63. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
    Fanouriakis A; Kostopoulou M; Andersen J; Aringer M; Arnaud L; Bae SC; Boletis J; Bruce IN; Cervera R; Doria A; Dörner T; Furie RA; Gladman DD; Houssiau FA; Inês LS; Jayne D; Kouloumas M; Kovács L; Mok CC; Morand EF; Moroni G; Mosca M; Mucke J; Mukhtyar CB; Nagy G; Navarra S; Parodis I; Pego-Reigosa JM; Petri M; Pons-Estel BA; Schneider M; Smolen JS; Svenungsson E; Tanaka Y; Tektonidou MG; Teng YO; Tincani A; Vital EM; van Vollenhoven RF; Wincup C; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2024 Jan; 83(1):15-29. PubMed ID: 37827694
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mortality in SLE patients compared with population controls in Finland in years 2000-2015.
    Elfving P; Kariniemi S; Kautiainen H; Virta LJ; Kaipiainen-Seppänen O; Puolakka K
    Rheumatology (Oxford); 2021 Sep; 60(9):4238-4244. PubMed ID: 33404636
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
    Sultan SM; Ioannou Y; Isenberg DA
    Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades.
    Moss KE; Ioannou Y; Sultan SM; Haq I; Isenberg DA
    Ann Rheum Dis; 2002 May; 61(5):409-13. PubMed ID: 11959764
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers.
    Pamuk ON; Akbay FG; Dönmez S; Yilmaz N; Calayir GB; Yavuz S
    Lupus; 2013 Nov; 22(13):1416-24. PubMed ID: 23929639
    [TBL] [Abstract][Full Text] [Related]  

  • 68. All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971-2013).
    Tselios K; Gladman DD; Sheane BJ; Su J; Urowitz M
    Ann Rheum Dis; 2019 Jun; 78(6):802-806. PubMed ID: 30992296
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study.
    Kim WU; Kim SI; Yoo WH; Park JH; Min JK; Kim SC; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    Lupus; 1999; 8(7):552-7. PubMed ID: 10483034
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.
    Akhavan PS; Su J; Lou W; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2013 Jun; 40(6):831-41. PubMed ID: 23588942
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
    Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis.
    Ballocca F; D'Ascenzo F; Moretti C; Omedè P; Cerrato E; Barbero U; Abbate A; Bertero MT; Zoccai GB; Gaita F
    Eur J Prev Cardiol; 2015 Nov; 22(11):1435-41. PubMed ID: 25139772
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study.
    Guo J; Ren Z; Li J; Li T; Liu S; Yu Z
    Arthritis Res Ther; 2020 Jun; 22(1):159. PubMed ID: 32586407
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical manifestations and survival among adults with (SLE) according to age at diagnosis.
    Merola JF; Bermas B; Lu B; Karlson EW; Massarotti E; Schur PH; Costenbader KH
    Lupus; 2014 Jul; 23(8):778-84. PubMed ID: 24608964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality.
    Teh CL; Wan SA; Ling GR
    Clin Rheumatol; 2018 Aug; 37(8):2081-2086. PubMed ID: 29667100
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes.
    Zhang S; Ye Z; Li C; Li Z; Li X; Wu L; Liu S; Zuo X; Zhu P; Wang Z; Wang Y; Wang Z; Zhao J; Wang Q; Tian X; Li M; Zeng X
    Lupus; 2019 Apr; 28(5):635-641. PubMed ID: 30939980
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study.
    Kim WU; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    Clin Exp Rheumatol; 1999; 17(5):539-45. PubMed ID: 10544836
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia.
    Seo MR; Chae J; Kim YM; Cha HS; Choi SJ; Oh S; Roh CR
    Lupus; 2019 May; 28(6):722-730. PubMed ID: 30971164
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients.
    Calvo-Alén J; Alarcón GS; Campbell R; Fernández M; Reveille JD; Cooper GS
    Rheumatology (Oxford); 2005 Sep; 44(9):1186-9. PubMed ID: 15956088
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Central nervous system infections in Filipino patients with systemic lupus erythematosus.
    Vargas PJ; King G; Navarra SV
    Int J Rheum Dis; 2009 Sep; 12(3):234-8. PubMed ID: 20374352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.